Search - tctmd.com

Displaying 1 - 20 of 15202

Sort: Relevancy | Date

News Daily News

In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients

Todd Neale

January 25, 2016

News Features

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Michael O'Riordan

January 25, 2016

News Industry News

Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016

January 25, 2016

News Industry News

First U.S. Patient Treated Following FDA Approval of Cook Medical’s Zenith Alpha™ Thoracic Endovascular Graft

January 25, 2016

News Daily News

在他汀类药物治疗基础上添加依泽替米贝可以降低首次和后续心血管事件的风险：IMPROVE-IT 分析

Michael O'Riordan

January 26, 2016

News Daily News

Análisis del IMPROVE-IT: La Incorporación de Ezetimibe al Tratamiento con Estatinas Reduce el Riesgo de Sufrir Primeros y Subsiguientes Episodios CV

Michael O'Riordan

January 26, 2016

News Daily News

Adding Ezetimibe to Statin Therapy Reduces Risk of First and Subsequent CV Events: IMPROVE-IT Analysis

Michael O'Riordan

January 26, 2016

News Daily News

AHA 报告为改善女性急性心梗患者结局铺路

Caitlin E. Cox

January 25, 2016

News Daily News

Un Documento de AHA Defiende que Hay que Mejorar los Resultados de Mujeres Víctimas de IAM

Caitlin E. Cox

January 25, 2016

News Daily News

AHA Document Builds the Case for How to Improve Outcomes for Women With Acute MI

Caitlin E. Cox

January 25, 2016

News Daily News

Low Serum Magnesium Tied to Cardiovascular Mortality, but Mechanisms Murky

Todd Neale

January 24, 2016

News Industry News

U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® (empagliflozin)

January 24, 2016

News Daily News

心动过缓与不良结局相关，但只有在服用影响心率的药物时才成立

Yael L. Maxwell

January 25, 2016

News Daily News

La Bradicardia se asocia a Resultados Adversos pero Solo Con Fármacos Modificadores de la Frecuencia Cardíaca

Yael L. Maxwell

January 25, 2016

News Daily News

Bradycardia Linked to Adverse Outcomes, But Only in Conjunction With Heart Rate-Modifying Drugs

Yael L. Maxwell

January 25, 2016

News Opinion Editor's Corner

数据的礼物：医学期刊支持将数据公开披露作为发表的前提

Shelley Wood

January 24, 2016

News Opinion Editor's Corner

El Regalo de los Datos: Las Revistas Médicas Exigen que se Hagan Públicos los Datos como un Requisito Indispensable en Materia de Publicación

Shelley Wood

January 24, 2016

News Opinion Editor's Corner

The Gift of Data: Medical Journals Back Public Data Disclosure as Prerequisite for Publishing

Shelley Wood

January 24, 2016

News Industry News

Mercator MedSystems Announces First Patient Enrolled in Below the Knee (BTK) Clinical Trial

January 21, 2016

News Industry News

Amgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol

January 21, 2016

Advertisement

In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016

First U.S. Patient Treated Following FDA Approval of Cook Medical’s Zenith Alpha™ Thoracic Endovascular Graft

在他汀类药物治疗基础上添加依泽替米贝可以降低首次和后续心血管事件的风险：IMPROVE-IT 分析

Análisis del IMPROVE-IT: La Incorporación de Ezetimibe al Tratamiento con Estatinas Reduce el Riesgo de Sufrir Primeros y Subsiguientes Episodios CV

Adding Ezetimibe to Statin Therapy Reduces Risk of First and Subsequent CV Events: IMPROVE-IT Analysis

AHA 报告为改善女性急性心梗患者结局铺路

Un Documento de AHA Defiende que Hay que Mejorar los Resultados de Mujeres Víctimas de IAM

AHA Document Builds the Case for How to Improve Outcomes for Women With Acute MI

Low Serum Magnesium Tied to Cardiovascular Mortality, but Mechanisms Murky

U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® (empagliflozin)

心动过缓与不良结局相关，但只有在服用影响心率的药物时才成立

La Bradicardia se asocia a Resultados Adversos pero Solo Con Fármacos Modificadores de la Frecuencia Cardíaca

Bradycardia Linked to Adverse Outcomes, But Only in Conjunction With Heart Rate-Modifying Drugs

数据的礼物：医学期刊支持将数据公开披露作为发表的前提

El Regalo de los Datos: Las Revistas Médicas Exigen que se Hagan Públicos los Datos como un Requisito Indispensable en Materia de Publicación

The Gift of Data: Medical Journals Back Public Data Disclosure as Prerequisite for Publishing

Mercator MedSystems Announces First Patient Enrolled in Below the Knee (BTK) Clinical Trial

Amgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content